A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function after Kidney Transplantation
Clinical Trial Grant
Administered By
Surgery, Abdominal Transplant Surgery
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
April 28, 2025
End Date
April 30, 2030
Administered By
Surgery, Abdominal Transplant Surgery
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
April 28, 2025
End Date
April 30, 2030